Malin Corporation | MLC - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
ALKERMES USD 165.61M 503K 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Eurofins Scientific SE EUR 177.9M 0 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Lonza CHF 68.64M 0 2025-12
Malin Corporation EUR 200K 0 2024-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Ovoca Bio EUR 29.49M 18.43M 2025-06
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12